A critical appraisal of blood-based biomarkers for Alzheimer’s disease-Reference-Cited by-同舟云学术

A critical appraisal of blood-based biomarkers for Alzheimer’s disease

Published:2024-04 Issue: Volume:96 Page:102290
ISSN:1568-1637
Container-title:Ageing Research Reviews
language:en
Short-container-title:Ageing Research Reviews

Author:

Lista Simone^ORCID,Mapstone Mark,Caraci Filippo,Emanuele Enzo,López-Ortiz Susana,Martín-Hernández Juan,Triaca Viviana,Imbimbo Camillo,Gabelle Audrey,Mielke Michelle M.,Nisticò Robert,Santos-Lozano Alejandro,Imbimbo Bruno P.

Funder

Ministerio de Ciencia e Innovación

Publisher

Elsevier BV

Reference277 articles.

1. Evidence That Lumipulse G Ptau217 Plasma Measurements Have The Ability To Quantitatively Assess Tau Stage And Burden;Bannon,2023

2. Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer’s disease;Aguillon;Alzheimer’S. Dement.,2023

3. The performance of AlzoSure® predict in stratifying the risk to experience a significant cognitive deterioration, due to Alzheimer’s disease;Agus;Alzheimer’S. Dement.,2023

4. Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis;Alagaratnam;BMJ Neurol. Open,2021

5. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer’s disease;Alawode;J. Int. Med.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more;Frontiers in Aging Neuroscience;2024-09-04

2. Molecular Engineering of a Doubly Quenched Fluorescent Probe Enables Ultrasensitive Detection of Biothiols in Highly Diluted Plasma and High-Fidelity Imaging of Dihydroartemisinin-Induced Ferroptosis;Analytical Chemistry;2024-08-01

3. Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives;International Journal of Molecular Sciences;2024-07-25

4. Alzheimer disease blood biomarkers: considerations for population-level use;Nature Reviews Neurology;2024-06-11